is to explore the regulation of eukaryotic gene expression programs at the transcriptional and post-transcriptional levels and their connection to signaling pathways, using a combination of cell and molecular biology studies with transcriptomics and bioinformatic approaches.
The group aims to tackle scientific problems that are relevant for human health and disease therapy and to explore applications to the development of targeted therapeutic strategies bridging Gene Expression Mechanisms to Systems Function and Therapy Development. The group is composed of four research teams located at the academic campus of FCUL (RNA Biology and Bioinformatics lab, lead by the group coordinator), the INSA campus (‘Signaling pathways in gene expression lab’ and the ‘mRNA Metabolism lab’), and at the University of Trás-os-Montes (‘Genome organization lab’). Each team explores independent but interconnected scientific aims within the overall objectives, contributing towards the development of a coherent research program in the area of eukaryotic control of gene expression.
A significant part of the group’s research involves the application and development of bioinformatic tools for RNA-seq data analysis, supported by a server infrastructure with capacity for analysis of eukaryotic transcriptomes.
Specific research interests include: 1) basic mechanism of gene expression and RNA-based therapy developments; 2) characterization of gene expression pathways underlying rare genetic disorders; 3) role of RNA pathways in neuronal function and neurodegeneration; 4) signaling pathways in cell function and cancer and their connection to splicing; 5) translational control and mRNA surveillance in cell function and cancer; 6) role of repetitive DNA sequences in genome organization and function.
Due to the focus on fundamental pathways for cell function and regulation and the extended use of transcriptomics and bioinformatic approaches, the GE&R group is in a pivotal position within BioISI contributing towards all thematic strands (TS) and being particularly involved in the Biomedicine and Bioinformatics and Modeling TS.